Obsessive-compulsive disorder
Definition:
References:
-
[1]. Aline Santos Sampaio, et al. COMT and MAO-A polymorphisms and obsessive-compulsive disorder: a family-based association study. PLoS One. 2015 Mar 20;10(3):e0119592. [Content Brief]
[2]. Bruno Millet, et al. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):55-9. [Content Brief]
[3]. Diane E Dickel, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 2006 Jul;63(7):778-85. [Content Brief]
[4]. M H Bloch, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006 Jul;11(7):622-32. [Content Brief]
[5]. Raşit Tükel, et al. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):850-8. [Content Brief]
[6]. S Walitza, et al. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry. 2002;7(10):1054-7. [Content Brief]
[7]. Steven Taylor, et al. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev. 2011 Nov;31(7):1083-100. [Content Brief]
[8]. Xian-Zhang Hu, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006 May;78(5):815-826. [Content Brief]
[9]. Yaghoob Vakili, et al. Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder. Iran J Psychiatry Behav Sci. 2015 Jun;9(2):e845. [Content Brief]